Table of Content



Introduction
Attention Deficit Hyperactivity Disorder (ADHD) - Overview
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Development
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Assessment
Attention Deficit Hyperactivity Disorder (ADHD) - Companies Involved in Therapeutics Development
Attention Deficit Hyperactivity Disorder (ADHD) - Drug Profiles
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects
Attention Deficit Hyperactivity Disorder (ADHD) - Discontinued Products
Attention Deficit Hyperactivity Disorder (ADHD) - Product Development Milestones
Appendix



List of Figures



Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables



Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by 4P-Pharma SAS, H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by AgoneX Biopharmaceuticals Inc, H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Altus Formulation Inc, H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H2 2020 (Contd..1), H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H2 2020 (Contd..2), H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H2 2020 (Contd..3), H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H2 2020 (Contd..4), H2 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Discontinued Products, H2 2020